Suppr超能文献

PRIAMUS——颈动脉支架置入术中近端血流阻断脑保护:来自意大利多中心注册研究的结果

PRIAMUS--proximal flow blockage cerebral protectIon during carotid stenting: results from a multicenter Italian registry.

作者信息

Coppi G, Moratto R, Silingardi R, Rubino P, Sarropago G, Salemme L, Cremonesi A, Castriota F, Manetti R, Sacca S, Reimers B

机构信息

Vascular Surgery Department, University of Modena-Reggio Emilia, S. Agostino Hospital, Modena, Italy.

出版信息

J Cardiovasc Surg (Torino). 2005 Jun;46(3):219-27.

Abstract

AIM

The aim of this Italian prospective registry was to evaluate the applicability and efficacy of the Mo.Ma Device (Invatec, Roncadelle, Italy) for the prevention of cerebral embolization during carotid artery stenting (CAS) in a real world population.

METHODS

In 4 Italian centers, 416 patients (300 men; mean age 71.6+/-9 years) between October 2001 and March 2005 were enrolled in a prospective registry. Two-hundred and sixty-four symptomatic (63.46%) with >50% diameter stenosis and 152 (36.54%) asymptomatic patients with >70% diameter stenosis were included. The Mo.Ma Proximal Flow Blockage Embolic Protection System was used to perform protected CAS, achieving cerebral protection by endovascular clamping of the common carotid artery (CCA) and of the external carotid artery (ECA).

RESULTS

Technical success, defined as the ability to establish protection with the Mo.Ma device and to deploy the stent, was achieved in 412 cases (99.03%). The mean duration of flow blockage was 4.91+/-1.1 min. Transient intolerances to flow blockage were observed in 24 patients (5.76%), but in all cases the procedure was successfully completed. No peri-procedural strokes and deaths were observed. Complications during hospitalization included 16 minor strokes (3.84%), 3 transient ischemic attacks (0.72%), 2 deaths (0.48%) and 1 major stroke (0.24%). This resulted in a cumulative rate at discharge of 4.56% all strokes and deaths, and of 0.72% major strokes and deaths. All the patients underwent thirty-day follow-up. At thirty-day follow-up, there were no deaths and no minor and major strokes, confirming the overall cumulative 4.56% incidence of all strokes and deaths rate, and of 0.72% rate of major strokes and deaths at follow up. In 245 cases (58.89%) there was macroscopic evidence of debris after filtration of the aspirated blood.

CONCLUSIONS

This Italian multicenter registry confirms and further supports the efficacy and applicability of the endovascular clamping concept with proximal flow blockage in a broad patient series. Results match favorably with current available studies on carotid stenting with cerebral protection.

摘要

目的

这项意大利前瞻性注册研究旨在评估Mo.Ma装置(意大利隆卡代尔的英瓦特克公司生产)在真实世界人群的颈动脉支架置入术(CAS)中预防脑栓塞的适用性和有效性。

方法

在2001年10月至2005年3月期间,4个意大利中心的416例患者(300例男性;平均年龄71.6±9岁)被纳入前瞻性注册研究。纳入了264例症状性患者(63.46%),其直径狭窄>50%,以及152例无症状患者(36.54%),其直径狭窄>70%。使用Mo.Ma近端血流阻断栓子保护系统进行受保护的CAS,通过对颈总动脉(CCA)和颈外动脉(ECA)进行血管内夹闭来实现脑保护。

结果

412例(99.03%)实现了技术成功,即能够使用Mo.Ma装置建立保护并成功置入支架。平均血流阻断持续时间为4.91±1.1分钟。24例患者(5.76%)出现了对血流阻断的短暂不耐受,但所有病例手术均成功完成。未观察到围手术期卒中及死亡。住院期间的并发症包括16例轻度卒中(3.84%)、3例短暂性脑缺血发作(0.72%)、2例死亡(0.48%)和1例重度卒中(0.24%)。这导致出院时所有卒中和死亡的累积发生率为4.56%,重度卒中和死亡的累积发生率为0.72%。所有患者均接受了30天随访。在30天随访时,无死亡病例,无轻度和重度卒中,证实了所有卒中和死亡的总体累积发生率为4.56%,随访时重度卒中和死亡的发生率为0.72%。在245例(58.89%)病例中,抽吸血液过滤后有肉眼可见的碎片证据。

结论

这项意大利多中心注册研究证实并进一步支持了近端血流阻断血管内夹闭概念在广泛患者群体中的有效性和适用性。结果与目前关于有脑保护的颈动脉支架置入术的现有研究结果相符。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验